Y Intercept Hong Kong Ltd purchased a new stake in Maximus, Inc. (NYSE:MMS - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 10,824 shares of the health services provider's stock, valued at approximately $1,008,000.
A number of other institutional investors have also recently bought and sold shares of MMS. Assenagon Asset Management S.A. lifted its stake in Maximus by 151.6% in the 2nd quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider's stock valued at $19,980,000 after acquiring an additional 140,481 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its position in shares of Maximus by 942.9% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider's stock worth $27,707,000 after purchasing an additional 292,300 shares in the last quarter. SG Americas Securities LLC lifted its position in shares of Maximus by 609.6% in the second quarter. SG Americas Securities LLC now owns 14,278 shares of the health services provider's stock worth $1,224,000 after purchasing an additional 12,266 shares in the last quarter. Versor Investments LP boosted its holdings in Maximus by 213.5% during the third quarter. Versor Investments LP now owns 8,500 shares of the health services provider's stock worth $792,000 after purchasing an additional 5,789 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Maximus by 12.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 929,066 shares of the health services provider's stock valued at $86,552,000 after purchasing an additional 102,350 shares in the last quarter. Institutional investors own 97.21% of the company's stock.
Insider Buying and Selling
In other news, insider Michelle F. Link sold 2,208 shares of the firm's stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total value of $163,016.64. Following the completion of the sale, the insider now directly owns 6,567 shares of the company's stock, valued at $484,841.61. This trade represents a 25.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 1.40% of the stock is owned by corporate insiders.
Maximus Stock Down 1.2 %
MMS stock traded down $0.86 during mid-day trading on Friday, reaching $69.85. The company had a trading volume of 665,146 shares, compared to its average volume of 432,174. The company has a market capitalization of $4.21 billion, a price-to-earnings ratio of 14.13 and a beta of 0.73. Maximus, Inc. has a 52 week low of $69.72 and a 52 week high of $93.97. The stock has a 50 day simple moving average of $83.01 and a two-hundred day simple moving average of $86.70. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.49.
Maximus Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Investors of record on Friday, November 15th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.72%. Maximus's dividend payout ratio is presently 24.00%.
Analysts Set New Price Targets
Separately, StockNews.com downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, November 28th.
Get Our Latest Stock Analysis on Maximus
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.